Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CKD-581
DRUG
2 trials
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
Lymphoma
Multiple Myeloma
Myeloma, Multiple
Phase 1
Safety and Pharmacokinetic Profile of CKD-581
Completed
NCT01580371
Chong Kun Dang Pharmaceutical
Lymphoma, Multiple Myeloma
Start: 2012-05-31
End: 2016-06-30
Updated: 2016-10-06
CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT03051841
Chong Kun Dang Pharmaceutical
Myeloma, Multiple
Start: 2017-01-31
End: 2022-11-30
Target: 18
Updated: 2020-02-24